Kiyoshi Ohtani
Sanda, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Murine Embryonic Stem Cells Possess Distinct E2F Activity That Activates Tumor Suppressor Promoter Elements.
Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: November 01, 2025
Distinct Regulation of the ARF and TAp73 Tumor Suppressor Genes by the Transcription Factor E2F1 Enables Discrimination of Cancer Cells from Normal Growing Cells.
Journal: Cells
Published: October 30, 2025
The Transcriptional Coactivator DEAD/H Box 5 (DDX5) Gene Is a Target of the Transcription Factor E2F1 Deregulated from the Tumor Suppressor pRB.
Journal: Genes
Published: July 13, 2025
DEAD/H Box 5 (DDX5) Augments E2F1-Induced Cell Death Independent of the Tumor Suppressor p53.
Journal: International journal of molecular sciences
Published: November 06, 2024
The N-Terminal Region of the Transcription Factor E2F1 Contains a Novel Transactivation Domain and Recruits General Transcription Factor GTF2H2.
Journal: Biomolecules
Published: September 13, 2024
Non-canonical olfactory pathway activation induces cell fusion of cervical cancer cells.
Journal: Neoplasia (New York, N.Y.)
Published: July 25, 2024
Trans-Activation of the Coactivator-Associated Arginine Methyltransferase 1 (Carm1) Gene by the Oncogene Product Tax of Human T-Cell Leukemia Virus Type 1.
Journal: Genes
Published: April 14, 2024
Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression.
Journal: Biology
Published: November 06, 2023
Engineered Polymeric Nanovector for Intracellular Peptide Delivery in Antitumor Therapy.
Journal: International journal of nanomedicine
Published: July 18, 2023
Last Updated: 09/26/2026